entertainment -WSS

entertainment

author：focus 2025-09-28 20:32:00 - browse：11152

Sammy Kimball for STAT

Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally time for Novavax to shine?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Bob Herman joins us to explain his year-long investigation into some brazen conflicts of interest in the world of prescription drug pricing. Then, STAT’s Helen Branswell calls in to walk us through a news-packed week for vaccines, including weighty decisions for Covid-19 and RSV.

For more on what we cover, here’s the story on conflicts of interest; here’s the latest on RSV vaccines; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Why getting cancer drugs just got harder for rural patients

knowledge

WSS

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Pfizer highlights cancer drugs it thinks could reignite investor interest

Eisai exec who led development of Alzheimer’s drug to retire

Pfizer highlights cancer drugs it thinks could reignite investor interest

Wikipedia

entertainment

explore

Dobbs anniversary: the lost opportunity of abortion as health care

Biden declares emergency in flood

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

An inside look at PIPEs, biotech's buzzy new financing tool

Alkermes shareholders re

Parents surprise family after baby discharged from NICU after 170 days

Guidelines to prevent youth baseball injuries need more muscle

Kenai launches with $82 million for Parkinson’s stem cell therapy

Apple is now the first public company to be valued at $3 trillion

Congress gives doctors Medicare pay bump

leisure time

Biden targets hefty hospital 'facility fees' that often surprise patients

A Q&A with Aletha Maybank, AMA’s chief health equity officer

ACA's risk program benefits Blue Cross Blue Shield insurers

An inside look at PIPEs, biotech's buzzy new financing tool

RSV vaccines may be linked to small increased risk of developing GBS

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

knowledge

hotspot

hotspot